☰

Ali Ramezani, Ph.D. - Publications

Affiliations: 
2002 University of Toronto, Toronto, ON, Canada 
Area:
Microbiology Biology, Molecular Biology, Mental Health
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ramezani A, Dubrovsky L, Pushkarsky T, Sviridov D, Karandish S, Raj DS, Fitzgerald ML, Bukrinsky M. Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection. The Journal of Pharmacology and Experimental Therapeutics. 354: 376-83. PMID 26126533 DOI: 10.1124/Jpet.115.224485  0.401
2011 Ramezani A, Zweier-Renn LA, Hawley RG. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice. Thrombosis and Haemostasis. 105: 676-87. PMID 21264447 DOI: 10.1160/Th10-11-0725  0.337
2010 Ramezani A, Hawley RG. Strategies to insulate lentiviral vector-expressed transgenes. Methods in Molecular Biology (Clifton, N.J.). 614: 77-100. PMID 20225037 DOI: 10.1007/978-1-60761-533-0_5  0.401
2010 Zweier-Renn LA, Hawley TS, Burkett S, Ramezani A, Riz I, Adler RL, Hickstein DD, Hawley RG. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1. Genes, Chromosomes & Cancer. 49: 119-31. PMID 19862821 DOI: 10.1002/Gcc.20725  0.378
2010 Zweier-Renn LA, Hawley TS, Ramezani A, Riz I, Hawley RG. Abstract 2965: Dissecting the molecular mechanism of TLX1-mediated T-cell acute lymphoblastic leukemia development using an in vitro immortalization model Cancer Research. 70: 2965-2965. DOI: 10.1158/1538-7445.Am10-2965  0.391
2009 Ramezani A, Hawley RG. Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector. Blood. 114: 526-34. PMID 19470695 DOI: 10.1182/Blood-2009-01-199653  0.328
2008 Ramezani A, Hawley TS, Hawley RG. Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential. Stem Cells (Dayton, Ohio). 26: 3257-66. PMID 18787211 DOI: 10.1634/Stemcells.2008-0258  0.353
2008 Ramezani A, Hawley TS, Hawley RG. Reducing the genotoxic potential of retroviral vectors. Methods in Molecular Biology (Clifton, N.J.). 434: 183-203. PMID 18470646 DOI: 10.1007/978-1-60327-248-3_12  0.394
2007 Hong S, Hwang DY, Yoon S, Isacson O, Ramezani A, Hawley RG, Kim KS. Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1630-9. PMID 17609656 DOI: 10.1038/Sj.Mt.6300251  0.365
2006 Hawley RG, Ramezani A, Hawley TS. Hematopoietic stem cells. Methods in Enzymology. 419: 149-79. PMID 17141055 DOI: 10.1016/S0076-6879(06)19007-2  0.322
2006 Ramezani A, Hawley TS, Hawley RG. Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 245-54. PMID 16731046 DOI: 10.1016/J.Ymthe.2006.04.005  0.401
2006 Ramezani A, Ma XZ, Ameli M, Arora A, Joshi S. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes. Frontiers in Bioscience : a Journal and Virtual Library. 11: 2940-8. PMID 16720366 DOI: 10.2741/2023  0.608
2005 Akimov SS, Ramezani A, Hawley TS, Hawley RG. Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells. Stem Cells (Dayton, Ohio). 23: 1423-33. PMID 16144874 DOI: 10.1634/Stemcells.2005-0390  0.32
2005 Siatskas C, Underwood J, Ramezani A, Hawley RG, Medin JA. Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1752-4. PMID 16076962 DOI: 10.1096/Fj.05-4006Fje  0.327
2005 Akimov SS, Ramezani A, Hawley TS, Hawley RG. Immortalization of Human Umbilical Cord Blood-Derived Hematopoietic Progenitor Cells. Blood. 106: 1712-1712. DOI: 10.1182/Blood.V106.11.1712.1712  0.352
2005 Ramezani A, Hawley TS, Hawley RG. 89. Amelioration of Gamma Retroviral Silencing during Embryonic Stem Cell-Derived Hematopoiesis: Preclinical Assessment of Safety-Improved Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.067  0.38
2004 Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 892-902. PMID 15509507 DOI: 10.1016/J.Ymthe.2004.08.006  0.377
2004 Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. 186. Phenotypic Correction of Hemophilic Mice Using Hematopoietic Stem Cells Transduced with an MSCV-Based Oncoretroviral Vector Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.145  0.391
2003 Yamada K, Ramezani A, Hawley RG, Ebell W, Arwert F, Arnold LW, Walsh CE. Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 600-10. PMID 14529833 DOI: 10.1016/S1525-0016(03)00223-5  0.395
2003 Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood. 101: 4717-24. PMID 12586614 DOI: 10.1182/Blood-2002-09-2991  0.389
2003 Saenko EL, Ananyeva NM, Moayeri M, Ramezani A, Hawley RG. Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A. Current Gene Therapy. 3: 27-41. PMID 12553533 DOI: 10.2174/1566523033347417  0.37
2003 Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells (Dayton, Ohio). 21: 111-7. PMID 12529558 DOI: 10.1634/Stemcells.21-1-111  0.407
2003 Ramezani A, Hawley RG. Human immunodeficiency virus type 1-based vectors for gene delivery to human hematopoietic stem cells. Methods in Molecular Medicine. 76: 467-92. PMID 12526180 DOI: 10.1385/1-59259-304-6:467  0.358
2002 Ramezani A, Hawley RG. Generation of HIV-1-based lentiviral vector particles. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 16.22. PMID 18265303 DOI: 10.1002/0471142727.Mb1622S60  0.384
2002 Ramezani A, Hawley RG. Overview of the HIV-1 Lentiviral Vector System. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 16.21. PMID 18265302 DOI: 10.1002/0471142727.Mb1621S60  0.457
2002 Ramezani A, Ma XZ, Nazari R, Joshi S. Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1. Frontiers in Bioscience : a Journal and Virtual Library. 7: a29-36. PMID 11815297 DOI: 10.2741/Ramezani  0.631
2001 Wolfgang MJ, Eisele SG, Browne MA, Schotzko ML, Garthwaite MA, Durning M, Ramezani A, Hawley RG, Thomson JA, Golos TG. Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proceedings of the National Academy of Sciences of the United States of America. 98: 10728-32. PMID 11553810 DOI: 10.1073/Pnas.181336098  0.3
2000 Ramezani A, Hawley TS, Hawley RG. Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic Cells Molecular Therapy. 2: 458-469. PMID 11082319 DOI: 10.1006/Mthe.2000.0190  0.433
1999 Singwi S, Ramezani A, Ding SF, Joshi S. Targeted RNases: a feasibility study for use in HIV gene therapy. Gene Therapy. 6: 913-21. PMID 10505117 DOI: 10.1038/Sj.Gt.3300884  0.599
1997 Ramezani A, Ding SF, Joshi S. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes. Gene Therapy. 4: 861-7. PMID 9338016 DOI: 10.1038/sj.gt.3300474  0.603
1997 Ramezani A, Marhin W, Weerasinghe M, Joshi S. A rapid and efficient system for screening HIV-1 Pol mRNA-specific ribozymes. Canadian Journal of Microbiology. 43: 92-6. PMID 9057298 DOI: 10.1139/M97-013  0.613
1996 Ramezani A, Joshi S. Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo. Antisense & Nucleic Acid Drug Development. 6: 229-35. PMID 8915508 DOI: 10.1089/Oli.1.1996.6.229  0.629
1994 Cohli H, Fan B, Joshi RL, Ramezani A, Li X, Joshi S. Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s). Antisense Research and Development. 4: 19-26. PMID 7914762 DOI: 10.1089/Ard.1994.4.19  0.632
1993 Liem SE, Ramezani A, Li X, Joshi S. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance. Human Gene Therapy. 4: 625-34. PMID 8280800 DOI: 10.1089/Hum.1993.4.5-625  0.615
Show low-probability matches.